Life Sciences
Research on life sciences detailed by C. Lara-Bohórquez and co-authors
Published in Cancer Weekly, July 1st, 2008
Scientists discuss in 'TP53, BCL-2, p21Waf1/Cip1 and metallothionein as markers of differentiation, response to treatment and prognosis in neuroblastic tumors' new findings in life sciences. According to a study from Huelva, Spain, "To identify markers of response to therapy in neuroblastic tumors. A total of 58 patients with neuroblastic tumor (38 neuroblastomas, 13 ganglioneuroblastomas and 7 ganglioneuromas) were included in the study."
"TP53, BCL-2, p21Waf1/Cip1 and metallothionein were included as a biologic approach to tumor differentiation, response to therapy and prognosis. Patients who died of disease had the following immunophenotype: BCL-2 (9 of 10), nuclear...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-07-01)
More Articles from Cancer Weekly
- JAMA and Archives Journals
Radiation treatment for cancer after radical prostatectomy linked with increased survival - Addiction Medicine
"Magic Meadow Therapy - Guidance to Happiness" Now Available in English! - Cancer Gene Therapy
Data on cancer gene therapy described by researchers at Thomas Jefferson University - Cancer Gene Therapy
Data on cancer gene therapy discussed by P. Gao and colleagues - Cancer Gene Therapy
New cancer gene therapy data have been reported by researchers at University of Utrecht - Cancer Gene Therapy
New cancer gene therapy research has been reported by scientists at University of California - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
